Adjuvant chemotherapy in colorectal cancer. 2004

P Papadopoulou-Zekeridou, and E Alexandridis, and I Delithanasis, and T Zekeridis, and F Lagra, and X Krokidis, and N Lazaridis
1st Department of Internal Medicine, Kavala General Hospital, 61 Amerikanikou Erythrou Stavrou, 65201 Kavala, Greece.

Our aim was to study the three-fold response to treatment, survival rates and toxicity. METHODS We review 76 patients (median age 66.2 years) affected with the disease. All received adjuvant chemotherapy, while 13 with rectal cancer were subjected to radiation too. Patients were staged after Duke's classification. RESULTS Recurrence was noted in 15 patients, 3 at stage B and 12 at stage C; median recurrence-free interval was 18.9 months. Patients without relapse had a median disease-free period of 35.9 months. Median overall survival was 35.21 months. The 5-year survival mark have surpassed 14 patients (3 with recurrent disease): 8 at stage B and 6 at stage C. Ten have died; median survival in these patients was 30.5 months. No patients suffered from severe bone marrow toxicity; mucositis and diarrhoea grade III/IV was noted in 10 patients.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D003082 Colectomy Surgical resection of a portion of or the entire colon. Hemicolectomy,Large Bowel Resection,Colectomies,Hemicolectomies,Large Bowel Resections,Resection, Large Bowel,Resections, Large Bowel
D005260 Female Females
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

P Papadopoulou-Zekeridou, and E Alexandridis, and I Delithanasis, and T Zekeridis, and F Lagra, and X Krokidis, and N Lazaridis
September 1985, Canadian journal of surgery. Journal canadien de chirurgie,
P Papadopoulou-Zekeridou, and E Alexandridis, and I Delithanasis, and T Zekeridis, and F Lagra, and X Krokidis, and N Lazaridis
December 2007, Lancet (London, England),
P Papadopoulou-Zekeridou, and E Alexandridis, and I Delithanasis, and T Zekeridis, and F Lagra, and X Krokidis, and N Lazaridis
March 1995, Annals of the Royal College of Surgeons of England,
P Papadopoulou-Zekeridou, and E Alexandridis, and I Delithanasis, and T Zekeridis, and F Lagra, and X Krokidis, and N Lazaridis
March 2006, Gan to kagaku ryoho. Cancer & chemotherapy,
P Papadopoulou-Zekeridou, and E Alexandridis, and I Delithanasis, and T Zekeridis, and F Lagra, and X Krokidis, and N Lazaridis
November 2001, British journal of cancer,
P Papadopoulou-Zekeridou, and E Alexandridis, and I Delithanasis, and T Zekeridis, and F Lagra, and X Krokidis, and N Lazaridis
January 1996, British journal of hospital medicine,
P Papadopoulou-Zekeridou, and E Alexandridis, and I Delithanasis, and T Zekeridis, and F Lagra, and X Krokidis, and N Lazaridis
October 2002, Current gastroenterology reports,
P Papadopoulou-Zekeridou, and E Alexandridis, and I Delithanasis, and T Zekeridis, and F Lagra, and X Krokidis, and N Lazaridis
February 2016, Gan to kagaku ryoho. Cancer & chemotherapy,
P Papadopoulou-Zekeridou, and E Alexandridis, and I Delithanasis, and T Zekeridis, and F Lagra, and X Krokidis, and N Lazaridis
January 1996, The oncologist,
P Papadopoulou-Zekeridou, and E Alexandridis, and I Delithanasis, and T Zekeridis, and F Lagra, and X Krokidis, and N Lazaridis
January 1995, Klinichna khirurhiia,
Copied contents to your clipboard!